• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRP2在黑色素瘤中的表达与一种短暂的细胞状态、T细胞浸润增加相关,且受IFNy信号上调。

LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is Upregulated by IFNy Signaling.

作者信息

Rasmussen Martin Q, Bønnelykke-Behrndtz Marie L, Merrild Camilla, Tvilling Ida, Christensen Julie N, Nielsen Morten M, Georgsen Jeanette B, Naumann Nina, Gudbergsson Johann M, Etzerodt Anders, Pedersen Jakob S, Jenkins Russell W, Degn Søren E, Moestrup Søren K, Schmidt Henrik, Steiniche Torben, Madsen Mette

机构信息

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Department of Plastic- and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Pigment Cell Melanoma Res. 2025 Sep;38(5):e70053. doi: 10.1111/pcmr.70053.

DOI:10.1111/pcmr.70053
PMID:40913277
Abstract

Low density lipoprotein receptor-related protein 2 (LRP2) is a 600 kilodalton multi-ligand endocytic membrane receptor expressed in several cell types during fetal development, including neuroepithelial cells, and in select absorptive epithelial cells in the adult. In epithelial cancers, LRP2 expression is associated with a differentiated tumor cell state and better prognosis. In previous work, we found that while LRP2 is not expressed in benign naevi, it is frequently acquired in melanoma. However, the molecular drivers of LRP2 expression in melanoma and characteristics of LRP2-expressing melanoma have yet to be described. Here, we show that LRP2 expression is related to a transitory melanoma cell state defined by co-expression of melanocyte lineage and neural crest transcriptional programs. Further, we reveal that melanoma LRP2 expression is increased in T cell-inflamed tumors and is directly upregulated through interferon-gamma signaling. Correlation of melanoma LRP2 expression with clinicopathological variables demonstrates that LRP2 expression is associated with low Breslow thickness and low clinical stage in primary melanomas. Taken together, the present study describes the characteristics of LRP2-expressing melanoma and reveals interferon-gamma signaling as a novel strong positive regulator of LRP2 expression in melanoma.

摘要

低密度脂蛋白受体相关蛋白2(LRP2)是一种600千道尔顿的多配体内吞膜受体,在胎儿发育期间于多种细胞类型中表达,包括神经上皮细胞,在成体中则表达于特定的吸收性上皮细胞。在上皮性癌中,LRP2表达与肿瘤细胞的分化状态及较好的预后相关。在先前的研究中,我们发现LRP2在良性痣中不表达,但在黑色素瘤中经常获得表达。然而,黑色素瘤中LRP2表达的分子驱动因素以及表达LRP2的黑色素瘤的特征尚未见报道。在此,我们表明LRP2表达与一种由黑素细胞谱系和神经嵴转录程序共表达所定义的短暂性黑色素瘤细胞状态相关。此外,我们揭示黑色素瘤LRP2表达在T细胞炎症性肿瘤中增加,并且通过γ干扰素信号直接上调。黑色素瘤LRP2表达与临床病理变量的相关性表明,LRP2表达与原发性黑色素瘤的低Breslow厚度和低临床分期相关。综上所述,本研究描述了表达LRP2的黑色素瘤的特征,并揭示γ干扰素信号是黑色素瘤中LRP2表达的一种新的强阳性调节因子。

相似文献

1
LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is Upregulated by IFNy Signaling.LRP2在黑色素瘤中的表达与一种短暂的细胞状态、T细胞浸润增加相关,且受IFNy信号上调。
Pigment Cell Melanoma Res. 2025 Sep;38(5):e70053. doi: 10.1111/pcmr.70053.
2
The landscape of long non-coding RNA during cSCC progression.皮肤鳞状细胞癌进展过程中长链非编码RNA的情况
Br J Dermatol. 2025 Mar 27. doi: 10.1093/bjd/ljaf108.
3
IgSF11-RAP1 signaling promotes cell migration and invasion of cutaneous melanoma.IgSF11-RAP1信号传导促进皮肤黑色素瘤的细胞迁移和侵袭。
Cell Commun Signal. 2025 Jul 10;23(1):330. doi: 10.1186/s12964-025-02245-5.
4
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.肢端雀斑样痣黑色素瘤国际患者队列中程序性细胞死亡蛋白1与细胞毒性T淋巴细胞相关蛋白4联合阻断治疗
Br J Dermatol. 2025 Jan 24;192(2):316-326. doi: 10.1093/bjd/ljae401.
5
Antigen presentation-related protein APOL3 promotes anti-tumor T cell immunity and suppresses melanoma cell growth in mice.抗原呈递相关蛋白APOL3促进抗肿瘤T细胞免疫并抑制小鼠黑色素瘤细胞生长。
Autoimmunity. 2025 Dec;58(1):2531833. doi: 10.1080/08916934.2025.2531833. Epub 2025 Jul 15.
6
VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study.A2058黑色素瘤细胞中VSIG-3/IGSF11基因沉默同时抑制黑色素瘤进展并诱导人T细胞产生抗肿瘤细胞因子谱:计算机模拟和体外研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3861-3880. doi: 10.1007/s00210-024-03491-z. Epub 2024 Oct 4.
7
Identification and validation of a KRAS-macrophage-associated gene signature as prognostic biomarkers and potential therapeutic targets in melanoma.鉴定和验证一种与KRAS-巨噬细胞相关的基因特征作为黑色素瘤的预后生物标志物和潜在治疗靶点。
Front Immunol. 2025 Jun 18;16:1566432. doi: 10.3389/fimmu.2025.1566432. eCollection 2025.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
WTAP is a promising diagnosis and treatment biomarker that inhibits the proliferation and invasion of melanoma cells.WTAP是一种有前景的诊断和治疗生物标志物,可抑制黑色素瘤细胞的增殖和侵袭。
Neoplasma. 2025 Jun;72(3):164-183. doi: 10.4149/neo_2025_250110N12. Epub 2025 May 20.
10
Construction and validation of a lipid metabolism-related genes prognostic signature for skin cutaneous melanoma.皮肤黑色素瘤脂质代谢相关基因预后特征的构建与验证
Biochem Biophys Res Commun. 2025 May 29;775:152115. doi: 10.1016/j.bbrc.2025.152115.